Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model
@article{Mohammad2001Bryostatin1I, title={Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model}, author={R. Mohammad and N. Adsay and P. Philip and G. Pettit and V. Vaitkevicius and F. Sarkar}, journal={Anti-Cancer Drugs}, year={2001}, volume={12}, pages={735-740} }
Pancreatic cancer has the worst prognosis of all cancers with a dismal 5-year survival rate. Hence, there is a tremendous need for development of new and effective therapy for this tumor. In an earlier study we reported a potent antitumor activity of Auristatin PE (AuriPE) against pancreatic tumor. In addition, we have also reported that bryostatin 1 (bryo1) induces differentiation of leukemia cells, but the effect of bryo1 has not been investigated in pancreatic tumors. This is the first… Expand
Topics from this paper
13 Citations
Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway.
- Medicine, Biology
- Carcinogenesis
- 2005
- 123
- PDF
Retracted: Cisplatin‐induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC‐3 pancreatic tumor xenografts
- Medicine
- Cancer
- 2006
- 76
Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis
- Biology
- Oncogene
- 2003
- 120
- PDF
Marine pharmacology in 2005-2006: antitumour and cytotoxic compounds.
- Biology, Medicine
- European journal of cancer
- 2008
- 150
- PDF
Marine pharmacology in 2001-2: antitumour and cytotoxic compounds.
- Biology, Medicine
- European journal of cancer
- 2004
- 50
- PDF
Interactions of antimitotic peptides and depsipeptides with tubulin.
- Chemistry, Medicine
- Biopolymers
- 2002
- 36
bryA: an unusual modular polyketide synthase gene from the uncultivated bacterial symbiont of the marine bryozoan Bugula neritina.
- Biology, Medicine
- Chemistry & biology
- 2004
- 121
References
SHOWING 1-10 OF 26 REFERENCES
Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity.
- Medicine
- Cancer research
- 1992
- 150
An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies.
- Medicine
- Clinical cancer research : an official journal of the American Association for Cancer Research
- 1998
- 38
- PDF
Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents.
- Medicine
- Pancreas
- 1998
- 42
Successful treatment of human Waldenström's macroglobulinemia with combination biological and chemotherapy agents.
- Medicine
- Cancer research
- 1994
- 55
Synergistic interaction of selected marine animal anticancer drugs against human diffuse large cell lymphoma
- Biology, Medicine
- Anti-cancer drugs
- 1998
- 20
Discovery of Solid Tumor Active Agents Using a Soft-Agar-Colony-Formation Disk-Diffusion-Assay
- Medicine
- 1992
- 49
Differential effects of bryostatin 1 on human non-Hodgkin's B-lymphoma cell lines.
- Biology, Medicine
- Leukemia research
- 1993
- 35
Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma.
- Biology, Medicine
- Pancreas
- 1999
- 15
Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
- Medicine
- Clinical cancer research : an official journal of the American Association for Cancer Research
- 1998
- 43
- PDF
Bryostatin 1‐Induced Modulation of the Acute Lymphoblastic Leukemia Cell Line Reh
- Medicine
- Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy
- 1993
- 23